Michigan.....60% gone.....poof...fanished....this whole process has the mark of a fucking consultant company all over it.
What's the overall structure (by product)? I mean, will there still be 2 Crestor reps in a territory? 2 reps with Onglyza? 2 with Symbicort, etc.?
Not really its just Michigan. They have not produced for any Pharma, Medical Equip, or Device Company for ever.
The Atlanta MCL/MCR region had less than a 10% loss. Lots of CNS reps switching to primary care, something they said would not happen. Don't know about the rest of the country.
Not really its just Michigan. They have not produced for any Pharma, Medical Equip, or Device Company for ever.